Confidence in Covid-19 vaccines is growing, with people’s willingness to have the shots increasing as they are rolled out across the world and concerns about possible side effects are fading, a 14-country survey showed on March 5.
Pfizer slashed in half the volume of Covid-19 vaccines the company will deliver to some EU countries this week, government officials said, as frustration over the U.S. drugmaker’s unexpected cut in supplies grows.
The European Union was asked to allow an extra dose of the Covid-19 vaccine developed by Pfizer and BioNTech to be taken from each vial, a practice allowed elsewhere that would make scarce supplies go further.
Global coronavirus infections exceeded 50 million, according to a Reuters tally, with a second wave of the virus in the past 30 days accounting for a quarter of the total.
Research Roundup: Two Types of Parkinson’s Disease and MoreAdults, Aging, Biomarkers, Boston University, Brain, Cell Stem Cell, Children, Denmark, Duke University, Epigenetic, Eye Health, Human beings, Inflammatory Proteins, Lung Inflammation, Lupus, Nerve Cells, Neurodegeneration, Parkinson’s disease, Primates, R&D, Research, Science Translational Medicine, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Universities
Researchers from Aarhus University in Denmark published research indicating that Parkinson’s disease is actually two types of the disease.
Denmark’s Novo Nordisk will cut around 250 jobs in the United States, but the drugmaker will also hire an as-yet undetermined number of staff to new positions.
Novo Nordisk said the world’s top maker of diabetes drugs will lay off 400 staff in Denmark and China as part of a broader restructuring of the company’s research and development organization.